Efficacy of ciclesonide inhaled once daily versus fluticasone propionate inhaled twice daily in children with asthma (6 to 11 y) (BY9010/M1-206)

Study identifier:BY9010/M1-206

ClinicalTrials.gov identifier:NCT00163462

EudraCT identifier:N/A

CTIS identifier:N/A

Study Complete

Official Title

Comparison of ciclesonide (80 mcg or 160 mcg once daily in the evening) and fluticasone propionate (100 mcg twice daily in the morning and evening) in pediatric asthma patients

Medical condition

asthma

Phase

Phase 3

Healthy volunteers

No

Study drug

Ciclesonide

Sex

All

Actual Enrollment

750

Study type

Interventional

Age

6 Years - 11 Years

Date

Study Start Date: 01 Oct 2004
Primary Completion Date: 01 Nov 2005
Study Completion Date: 01 Nov 2005

Study design

Allocation: Randomized
Endpoint Classification: Safety/Efficacy Study
Intervention Model: Parallel Assignment
Masking: Double Blind
Primary Purpose: Treatment

Verification:

Verified 01 Oct 2016 by AstraZeneca

Sponsors

AstraZeneca

Collaborators

-

Inclusion and exclusion criteria